₹ 28.39
-0.60 (-2.07%)
M
Mangalam Drugs & Organics
₹ 28.39
MANGALAM Financials Summary (Consolidated)
Mangalam Drugs & Organics revenue increased 39.16% quarter-on-quarter to ₹80 Cr in Sep 2026, while net loss narrowed to ₹7 Cr from ₹8 Cr in the previous quarter. Compared to the same quarter last year, revenue is up 61.46% and net loss narrowed to ₹7 Cr from ₹7 Cr a year ago. EPS for the quarter stood at -₹4.55, increased from -₹4.83 in the previous quarter and up from -₹4.64 a year ago.
Mangalam Drugs & Organics Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of MANGALAM Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
MANGALAM Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






